The translational value of calcium pyrophosphate deposition disease experimental mouse models
- PMID: 38846138
- PMCID: PMC11153760
- DOI: 10.3389/fmed.2024.1417318
The translational value of calcium pyrophosphate deposition disease experimental mouse models
Abstract
The deposition of calcium pyrophosphate (CPP) crystals in joint tissues causes acute and chronic arthritis that commonly affect the adult and elderly population. Experimental calcium pyrophosphate deposition disease (CPPD) models are divided into genetically modified models and crystal-induced inflammation models. The former do not reproduce phenotypes overlapping with the human disease, while in the latter, the direct injection of crystals into the ankles, dorsal air pouch or peritoneum constitutes a useful and reliable methodology that resembles the CPP induced-inflammatory condition in humans. The translational importance of the induced model is also strengthened by the fact that the key molecular and cellular mediators involved in inflammation are shared between humans and laboratory rodents. Although, in vivo models are indispensable tools for studying the pathogenesis of the CPPD and testing new therapies, their development is still at an early stage and major efforts are needed to address this issue. Here, we analyze the strenghts and limitations of each currently available CPPD in vivo model, and critically discuss their translational value.
Keywords: CPPD; arthritis; calcium pyrophosphate; inflammation; mouse models; pyrophosphate; translational models.
Copyright © 2024 Luisetto and Scanu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures

Similar articles
-
Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways.Front Immunol. 2018 Oct 9;9:2248. doi: 10.3389/fimmu.2018.02248. eCollection 2018. Front Immunol. 2018. PMID: 30356764 Free PMC article.
-
Ultrasound findings of calcium pyrophosphate deposition disease at metacarpophalangeal joints.Rheumatology (Oxford). 2022 Oct 6;61(10):3997-4005. doi: 10.1093/rheumatology/keac063. Rheumatology (Oxford). 2022. PMID: 35104308
-
Pathogenesis of calcium pyrophosphate deposition disease.Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101718. doi: 10.1016/j.berh.2021.101718. Epub 2021 Oct 22. Best Pract Res Clin Rheumatol. 2021. PMID: 34696986 Review.
-
Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.Arthritis Rheumatol. 2018 Aug;70(8):1182-1191. doi: 10.1002/art.40517. Epub 2018 Jun 14. Arthritis Rheumatol. 2018. PMID: 29609209 Free PMC article. Review.
-
Calcium pyrophosphate deposition disease: clinical manifestations.Reumatismo. 2012 Jan 19;63(4):246-52. doi: 10.4081/reumatismo.2011.246. Reumatismo. 2012. PMID: 22303531 Review.
References
Publication types
LinkOut - more resources
Full Text Sources